Cargando…

Correction to: Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial

Detalles Bibliográficos
Autores principales: Tsuda, Hitoshi, Kurosumi, Masafumi, Akiyama, Futoshi, Ohno, Shinji, Saji, Shigehira, Masuda, Norikazu, Shimomura, Akihiko, Sato, Nobuaki, Takao, Shintaro, Ohsumi, Shozo, Tokuda, Yutaka, Inaji, Hideo, Watanabe, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225968/
https://www.ncbi.nlm.nih.gov/pubmed/35499664
http://dx.doi.org/10.1007/s12282-022-01367-9
_version_ 1784733740858081280
author Tsuda, Hitoshi
Kurosumi, Masafumi
Akiyama, Futoshi
Ohno, Shinji
Saji, Shigehira
Masuda, Norikazu
Shimomura, Akihiko
Sato, Nobuaki
Takao, Shintaro
Ohsumi, Shozo
Tokuda, Yutaka
Inaji, Hideo
Watanabe, Toru
author_facet Tsuda, Hitoshi
Kurosumi, Masafumi
Akiyama, Futoshi
Ohno, Shinji
Saji, Shigehira
Masuda, Norikazu
Shimomura, Akihiko
Sato, Nobuaki
Takao, Shintaro
Ohsumi, Shozo
Tokuda, Yutaka
Inaji, Hideo
Watanabe, Toru
author_sort Tsuda, Hitoshi
collection PubMed
description
format Online
Article
Text
id pubmed-9225968
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-92259682022-06-25 Correction to: Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial Tsuda, Hitoshi Kurosumi, Masafumi Akiyama, Futoshi Ohno, Shinji Saji, Shigehira Masuda, Norikazu Shimomura, Akihiko Sato, Nobuaki Takao, Shintaro Ohsumi, Shozo Tokuda, Yutaka Inaji, Hideo Watanabe, Toru Breast Cancer Correction Springer Nature Singapore 2022-04-30 2022 /pmc/articles/PMC9225968/ /pubmed/35499664 http://dx.doi.org/10.1007/s12282-022-01367-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Tsuda, Hitoshi
Kurosumi, Masafumi
Akiyama, Futoshi
Ohno, Shinji
Saji, Shigehira
Masuda, Norikazu
Shimomura, Akihiko
Sato, Nobuaki
Takao, Shintaro
Ohsumi, Shozo
Tokuda, Yutaka
Inaji, Hideo
Watanabe, Toru
Correction to: Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial
title Correction to: Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial
title_full Correction to: Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial
title_fullStr Correction to: Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial
title_full_unstemmed Correction to: Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial
title_short Correction to: Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial
title_sort correction to: validation of a nuclear grading system for resected stage i–iiia, high-risk, node-negative invasive breast carcinoma in the n·sas-bc 01 trial
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225968/
https://www.ncbi.nlm.nih.gov/pubmed/35499664
http://dx.doi.org/10.1007/s12282-022-01367-9
work_keys_str_mv AT tsudahitoshi correctiontovalidationofanucleargradingsystemforresectedstageiiiiahighrisknodenegativeinvasivebreastcarcinomainthensasbc01trial
AT kurosumimasafumi correctiontovalidationofanucleargradingsystemforresectedstageiiiiahighrisknodenegativeinvasivebreastcarcinomainthensasbc01trial
AT akiyamafutoshi correctiontovalidationofanucleargradingsystemforresectedstageiiiiahighrisknodenegativeinvasivebreastcarcinomainthensasbc01trial
AT ohnoshinji correctiontovalidationofanucleargradingsystemforresectedstageiiiiahighrisknodenegativeinvasivebreastcarcinomainthensasbc01trial
AT sajishigehira correctiontovalidationofanucleargradingsystemforresectedstageiiiiahighrisknodenegativeinvasivebreastcarcinomainthensasbc01trial
AT masudanorikazu correctiontovalidationofanucleargradingsystemforresectedstageiiiiahighrisknodenegativeinvasivebreastcarcinomainthensasbc01trial
AT shimomuraakihiko correctiontovalidationofanucleargradingsystemforresectedstageiiiiahighrisknodenegativeinvasivebreastcarcinomainthensasbc01trial
AT satonobuaki correctiontovalidationofanucleargradingsystemforresectedstageiiiiahighrisknodenegativeinvasivebreastcarcinomainthensasbc01trial
AT takaoshintaro correctiontovalidationofanucleargradingsystemforresectedstageiiiiahighrisknodenegativeinvasivebreastcarcinomainthensasbc01trial
AT ohsumishozo correctiontovalidationofanucleargradingsystemforresectedstageiiiiahighrisknodenegativeinvasivebreastcarcinomainthensasbc01trial
AT tokudayutaka correctiontovalidationofanucleargradingsystemforresectedstageiiiiahighrisknodenegativeinvasivebreastcarcinomainthensasbc01trial
AT inajihideo correctiontovalidationofanucleargradingsystemforresectedstageiiiiahighrisknodenegativeinvasivebreastcarcinomainthensasbc01trial
AT watanabetoru correctiontovalidationofanucleargradingsystemforresectedstageiiiiahighrisknodenegativeinvasivebreastcarcinomainthensasbc01trial